{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T02:36:11Z","timestamp":1769308571805,"version":"3.49.0"},"reference-count":183,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.pharma.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T11:10:00Z","timestamp":1639048200000},"page":"409-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Interweaving of reactive oxygen species and major neurological and psychiatric disorders"],"prefix":"10.1016","volume":"80","author":[{"given":"M.D.","family":"Umare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.L.","family":"Wankhede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.K.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.V.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.G.","family":"Taksande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2170-0896","authenticated-orcid":false,"given":"M.J.","family":"Umekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.G.","family":"Mahore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.B.","family":"Kale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2021.11.004_bib0920","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Dr\u00f6ge","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharma.2021.11.004_bib0925","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1136\/jcp.54.3.176","article-title":"Antioxidants in health and disease","volume":"54","author":"Young","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.pharma.2021.11.004_bib0930","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.pharma.2021.11.004_bib0935","first-page":"1","article-title":"Oxidative stress: harms and benefits for human health","author":"Pizzino","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib0940","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10408690490468489","article-title":"Antioxidants and prevention of chronic disease","volume":"44","author":"Willcox","year":"2004","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/j.pharma.2021.11.004_bib0945","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharma.2021.11.004_bib0950","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.cellsig.2007.04.009","article-title":"Oxyl radicals, redox-sensitive signalling cascades and antioxidants","volume":"19","author":"Genestra","year":"2007","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharma.2021.11.004_bib0955","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1042\/BST0351147","article-title":"Biochemistry of oxidative stress","volume":"35","author":"Harwell","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.pharma.2021.11.004_bib0960","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/0002-9343(94)90292-5","article-title":"Reactive oxygen species and antioxidant vitamins: mechanisms of action","volume":"97","author":"Frei","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib0965","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1023\/B:MCBI.0000049134.69131.89","article-title":"Role of oxygen radicals in DNA damage and cancer incidence","volume":"266","author":"Valko","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib0970","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurasianjmed.2018.17397","article-title":"Reactive oxygen species: the dual role in physiological and pathological conditions of the human body","volume":"50","author":"Bardaweel","year":"2018","journal-title":"Eurasian J Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/428010","article-title":"Mechanism of oxidative stress in neurodegeneration","volume":"2012","author":"Gandhi","year":"2012","journal-title":"Oxid Med Cell Longev"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib0980","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1161\/01.RES.0000258450.44413.96","article-title":"Mitochondrial dysfunction in atherosclerosis","volume":"100","author":"Madamanchi","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib0985","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0891-5849(00)00317-8","article-title":"Mitochondrial free radical generation, oxidative stress, and aging","volume":"29","author":"Cadenas","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"10.1016\/j.pharma.2021.11.004_bib0990","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1124\/mol.64.5.1136","article-title":"Effect of glutathione depletion on sites and topology of superoxide and hydrogen peroxide production in mitochondria","volume":"64","author":"Han","year":"2003","journal-title":"Mol Pharmacol"},{"issue":"19","key":"10.1016\/j.pharma.2021.11.004_bib0995","first-page":"1","article-title":"Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers","volume":"6","author":"Li","year":"2013","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1000","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3109\/08830185.2012.755176","article-title":"Reactive oxygen species in the immune system","volume":"32","author":"Yang","year":"2013","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/982794","article-title":"Reactive oxygen species in skeletal muscle signaling","volume":"2012","author":"Barbieri","year":"2012","journal-title":"J Signal Transduct"},{"key":"10.1016\/j.pharma.2021.11.004_bib1010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JES.0b013e318245837b","article-title":"Do reactive oxygen species regulate skeletal muscle glucose uptake during contraction?","volume":"40","author":"Merry","year":"2012","journal-title":"Exerc Sport Sci Rev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1113\/jphysiol.2006.110601","article-title":"Role of reactive oxygen species in contraction-mediated glucose transport in mouse skeletal muscle","volume":"575","author":"Sandstr\u00f6m","year":"2006","journal-title":"J Physiol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1020","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1113\/expphysiol.2006.033506","article-title":"Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia","volume":"91","author":"Guzy","year":"2006","journal-title":"Exp Physiol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1025","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.mam.2016.01.002","article-title":"O2 sensing, mitochondria and ROS signaling: the fog is lifting","volume":"47\u201348","author":"Waypa","year":"2016","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1030","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1046\/j.1532-5415.2001.49217.x","article-title":"Telomeres and telomerase: basic science implications for aging","volume":"49","author":"Ahmed","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pharma.2021.11.004_bib1035","first-page":"72","article-title":"Modern biological theories of aging","volume":"1","author":"Jin","year":"2010","journal-title":"Aging Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","article-title":"Aging: a theory based on free radical and radiation chemistry","volume":"11","author":"Harman","year":"1956","journal-title":"J Gerontol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1532-5415.1972.tb00787.x","article-title":"The biologic clock: the mitochondria?","volume":"20","author":"Harman","year":"1972","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.pharma.2021.11.004_bib1050","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.pharma.2021.11.004_bib1055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5152\/eurasianjmed.2018.17397","article-title":"Reactive oxygen species: the dual role in physiological and pathological conditions of the human body","volume":"50","author":"Bardaweel","year":"2018","journal-title":"Eurasian J Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1060","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2105607","article-title":"Oxidative stress in neurodegenerative diseases: from a mitochondrial point of view","volume":"2019","author":"Cenini","year":"2019","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1065","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0891-5849(96)00380-2","article-title":"Down-regulation of mammalian mitochondrial RNAs during oxidative stress","volume":"22","author":"Crawford","year":"1997","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1070","first-page":"1","article-title":"The role of reactive oxygen species in the pathogenesis of Alzheimer's disease, Parkinson's disease, and Huntington's disease: a mini review","author":"Shanmugam","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1075","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.10389","article-title":"Role of mitochondrial dysfunction in Alzheimer's disease","volume":"70","author":"Castellani","year":"2002","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1085","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s007020050099","article-title":"Abnormalities of mitochondrial enzymes in Alzheimer disease","volume":"105","author":"Gibson","year":"1998","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharma.2021.11.004_bib1090","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/oxfordjournals.jbchem.a002969","article-title":"Microglia: activation and their significance in the central nervous system","volume":"130","author":"Nakajima","year":"2001","journal-title":"J Biochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1095","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2174\/157015911798376244","article-title":"Neuronal and vascular oxidative stress in Alzheimers disease","volume":"9","author":"Massaad","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1100","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3233\/JAD-2008-15110","article-title":"Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease","volume":"15","author":"Baldeiras","year":"2008","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1105","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/10715760802255764","article-title":"Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease","volume":"42","author":"Greilberger","year":"2008","journal-title":"Free Radic Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1110","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1046\/j.1471-4159.1998.71052034.x","article-title":"Increased nuclear DNA oxidation in the brain in Alzheimer's disease","volume":"71","author":"Gabbita","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1115","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1046\/j.1471-4159.1995.65052146.x","article-title":"Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation","volume":"65","author":"Hensley","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1120","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.exger.2004.06.020","article-title":"Mechanisms of the inhibitory effects of amyloid \u03b2-protein on synaptic plasticity","volume":"39","author":"Rowan","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer's disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1130","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3233\/JAD-2004-6208","article-title":"Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species","volume":"6","author":"Casadesus","year":"2004","journal-title":"J Alzheimer's Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1135","doi-asserted-by":"crossref","first-page":"9866","DOI":"10.1073\/pnas.94.18.9866","article-title":"Iron accumulation in Alzheimer disease is a source of redox-generated free radicals","volume":"94","author":"Smith","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2021.11.004_bib1140","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2174\/0929867053764635","article-title":"Metals, toxicity and oxidative stress","volume":"12","author":"Valko","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1145","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1046\/j.1471-4159.1997.68062451.x","article-title":"Oxidatively induced structural alteration of glutamine synthetase assessed by analysis of spin label incorporation kinetics: relevance to Alzheimer's disease","volume":"68","author":"Butterfield","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1150","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/497802","article-title":"Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?","volume":"2014","author":"Luque-Contreras","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1155","first-page":"234","article-title":"The importance of mitochondrial function in neurons: focus on therapeutic targets in neurodegeneration","volume":"12","author":"Badole","year":"2021","journal-title":"Adv Biores"},{"key":"10.1016\/j.pharma.2021.11.004_bib1160","first-page":"504","article-title":"Parkinson's disease and its management part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"P & T\u202f: a peer-reviewed journal for formulary management"},{"key":"10.1016\/j.pharma.2021.11.004_bib1165","first-page":"903","article-title":"Cognitive impairment and dementia in patients with Parkinson disease","volume":"9","author":"Leverenz","year":"2009","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0891988710383572","article-title":"The genetics of Parkinson disease","volume":"23","author":"Bekris","year":"2010","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1175","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson\u02bcs disease","volume":"55","author":"Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1180","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"\u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2021.11.004_bib1185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.arplant.55.031903.141701","article-title":"Reactive oxygen species: metabolism, oxidative stress, and signal transduction","volume":"55","author":"Apel","year":"2004","journal-title":"Annu Rev Plant Biol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1190","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.bbagen.2008.02.005","article-title":"Redox imbalance in Parkinson's disease","volume":"1780","author":"Chinta","year":"2008","journal-title":"Biochim Biophys Acta - Gen Subj"},{"key":"10.1016\/j.pharma.2021.11.004_bib1195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0197-0186(97)00031-4","article-title":"Free radicals and the pathobiology of brain dopamine systems","volume":"32","author":"Cadet","year":"1997","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharma.2021.11.004_bib1200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03033371","article-title":"Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease","volume":"5","author":"Gerlach","year":"2003","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1205","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1210","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1007\/s00018-012-1015-4","article-title":"Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors","volume":"69","author":"Surace","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1215","first-page":"332","article-title":"T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores","volume":"52","author":"Atasoy","year":"2004","journal-title":"Neurol India"},{"key":"10.1016\/j.pharma.2021.11.004_bib1220","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1046\/j.1471-4159.2003.01923.x","article-title":"Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease","volume":"86","author":"Faucheux","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1225","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gene.2013.07.085","article-title":"The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease","volume":"532","author":"Zuo","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.pharma.2021.11.004_bib1230","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1089\/ars.2005.7.1140","article-title":"Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources","volume":"7","author":"Adam-Vizi","year":"2005","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.pharma.2021.11.004_bib1235","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2147\/DDDT.S130514","article-title":"Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer's disease and Parkinson's disease","volume":"11","author":"Ganguly","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.pharma.2021.11.004_bib1240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-510X(99)00192-6","article-title":"Hydroxyl radical and superoxide dismutase in blood of patients with Parkinson's disease: relationship to clinical data","volume":"170","author":"Ihara","year":"1999","journal-title":"J Neurol Sci"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1245","first-page":"111","article-title":"Erythrocyte antioxidant enzymes in Parkinson's disease","volume":"121","author":"Abraham","year":"2005","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12640-013-9435-y","article-title":"Neuromelanin of the human substantia nigra: an update","volume":"25","author":"Zucca","year":"2013","journal-title":"Neurotox Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1255","doi-asserted-by":"crossref","first-page":"11869","DOI":"10.1073\/pnas.97.22.11869","article-title":"Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles","volume":"97","author":"Sulzer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2021.11.004_bib1260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson's disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front Neuroanat"},{"key":"10.1016\/j.pharma.2021.11.004_bib1265","doi-asserted-by":"crossref","first-page":"e38026","DOI":"10.1371\/journal.pone.0038026","article-title":"Human SOD2 modification by dopamine quinones affects enzymatic activity by promoting its aggregation: possible implications for Parkinson's disease","volume":"7","author":"Belluzzi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2021.11.004_bib1270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neuint.2012.10.001","article-title":"Vitamins K interact with N-terminus \u03b1-synuclein and modulate the protein fibrillization in vitro. Exploring the interaction between quinones and \u03b1-synuclein","volume":"62","author":"da Silva","year":"2013","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharma.2021.11.004_bib1275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.freeradbiomed.2013.06.030","article-title":"Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4","volume":"65","author":"Hauser","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1280","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cbi.2014.02.008","article-title":"Glutathione-mediated reversibility of covalent modification of ubiquitin carboxyl-terminal hydrolase L1 by 1,2-naphthoquinone through Cys152, but not Lys4","volume":"214","author":"Toyama","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.pharma.2021.11.004_bib1285","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.freeradbiomed.2013.12.015","article-title":"Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons","volume":"68","author":"Zhou","year":"2014","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1290","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2013.02.012","article-title":"Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging","volume":"541","author":"Ohtsuka","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharma.2021.11.004_bib1295","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.parkreldis.2014.04.005","article-title":"Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging","volume":"20","author":"Ohtsuka","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pharma.2021.11.004_bib1300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jprot.2013.07.015","article-title":"Combined enrichment of neuromelanin granules and synaptosomes from human substantia nigra pars compacta tissue for proteomic analysis","volume":"94","author":"Plum","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.pharma.2021.11.004_bib1305","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/2525967","article-title":"Oxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applications","volume":"2017","author":"Liu","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1310","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.tibs.2013.05.003","article-title":"Huntington's disease: underlying molecular mechanisms and emerging concepts","volume":"38","author":"Labbadia","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1315","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.tins.2008.09.004","article-title":"Mutant huntingtin and mitochondrial dysfunction","volume":"31","author":"Bossy-Wetzel","year":"2008","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1320","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nn884","article-title":"Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines","volume":"5","author":"Panov","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1325","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pharma.2021.11.004_bib1330","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.bbrc.2016.09.065","article-title":"Energy defects in Huntington's disease: why \u201cin vivo\u201d evidence matters","volume":"483","author":"Liot","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharma.2021.11.004_bib1335","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1389450115666140115113734","article-title":"The role of oxidative stress in Huntington's disease: are antioxidants good therapeutic candidates?","volume":"15","author":"Gil-Mohapel","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.pharma.2021.11.004_bib1340","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-160205","article-title":"Oxidative stress and Huntington's disease: the good, the bad, and the ugly","volume":"5","author":"Kumar","year":"2016","journal-title":"J Huntingtons Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1345","doi-asserted-by":"crossref","first-page":"18320","DOI":"10.1074\/jbc.M110.199448","article-title":"Cysteine oxidation within N-terminal mutant huntingtin promotes oligomerization and delays clearance of soluble protein","volume":"286","author":"Fox","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1350","doi-asserted-by":"crossref","first-page":"14995","DOI":"10.1073\/pnas.1308535110","article-title":"Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding","volume":"110","author":"Xiao","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharma.2021.11.004_bib1355","doi-asserted-by":"crossref","first-page":"34764","DOI":"10.1074\/jbc.M112.387035","article-title":"Post-aggregation oxidation of mutant huntingtin controls the interactions between aggregates","volume":"287","author":"Mitomi","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1360","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/XE8W-GLCJ-KEM6-39FH","article-title":"The epidemiology of depression in medical care","volume":"17","author":"Katon","year":"1987","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1365","doi-asserted-by":"crossref","DOI":"10.1001\/archpsyc.1997.01830230015002","article-title":"The clinical course of unipolar major depressive disorders","author":"Judd","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharma.2021.11.004_bib1370","first-page":"405","article-title":"The economic burden of depression in 1990","volume":"54","author":"Greenberg","year":"1993","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.pharma.2021.11.004_bib1375","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-0447.1997.tb09629.x","article-title":"Down-rating lifetime suicide risk in major depression","volume":"95","author":"Blair-West","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.pharma.2021.11.004_bib1380","first-page":"287","article-title":"The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression","volume":"29","author":"Maes","year":"2008","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.pharma.2021.11.004_bib1385","first-page":"462","article-title":"Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness","volume":"30","author":"Maes","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"key":"10.1016\/j.pharma.2021.11.004_bib1390","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","article-title":"The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression","volume":"24","author":"Maes","year":"2009","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1395","first-page":"470","article-title":"Coenzyme Q10 deficiency in myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME\/CFS due to cardiovascular disorder","volume":"30","author":"Maes","year":"2009","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"10.1016\/j.pharma.2021.11.004_bib1400","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.yco.0000194371.47685.f2","article-title":"An update on regional brain volume differences associated with mood disorders","volume":"19","author":"Campbell","year":"2006","journal-title":"Curr Opin Psychiatry"},{"issue":"9","key":"10.1016\/j.pharma.2021.11.004_bib1405","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.biopsych.2004.08.022","article-title":"Cellular changes in the postmortem hippocampus in major depression","volume":"56","author":"Stockmeier","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharma.2021.11.004_bib1410","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jad.2009.12.014","article-title":"Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease","volume":"125","author":"Maes","year":"2010","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharma.2021.11.004_bib1415","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cca.2005.01.005","article-title":"Gender differences in antioxidant capacity of rat tissues determined by 2,2\u2032-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays","volume":"140","author":"Katalinic","year":"2005","journal-title":"Comp Biochem Physiol Part C Toxicol Pharmacol"},{"issue":"12","key":"10.1016\/j.pharma.2021.11.004_bib1420","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1089\/ars.2012.4720","article-title":"Severe life stress and oxidative stress in the brain: from animal models to human pathology","volume":"18","author":"Schiavone","year":"2013","journal-title":"Antioxidants Redox Signal"},{"key":"10.1016\/j.pharma.2021.11.004_bib1425","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-0327(97)00166-3","article-title":"Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients","volume":"48","author":"Edwards","year":"1998","journal-title":"J Affect Disord"},{"key":"10.1016\/j.pharma.2021.11.004_bib1430","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-0-585-37970-8_2","article-title":"Major depression and activation of the inflammatory response system","volume":"461","author":"Maes","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1435","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/med.20073","article-title":"Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls","volume":"27","author":"Aldini","year":"2007","journal-title":"Med Res Rev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1440","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1179\/135100003225003393","article-title":"Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors","volume":"8","author":"Khanzode","year":"2003","journal-title":"Redox Rep"},{"key":"10.1016\/j.pharma.2021.11.004_bib1445","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/00004850-200403000-00006","article-title":"Antioxidant enzyme activities and oxidative stress in affective disorders","volume":"19","author":"Erkan Ozcan","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1450","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1139\/jpn.0935","article-title":"3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder","volume":"34","author":"Andreazza","year":"2009","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1455","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/gast.2001.20875","article-title":"Nitric oxide\u2013mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes","volume":"120","author":"Jaiswal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1460","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.mrfmmm.2006.06.003","article-title":"Malondialdehyde, a major endogenous lipid peroxidation product, sensitizes human cells to UV- and BPDE-induced killing and mutagenesis through inhibition of nucleotide excision repair","volume":"601","author":"Feng","year":"2006","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"10.1016\/j.pharma.2021.11.004_bib1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","article-title":"Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics","volume":"339","author":"Wu","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2021.11.004_bib1470","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/10590500902885684","article-title":"8-hydroxy-2\u2032-deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J Environ Sci Heal Part C"},{"key":"10.1016\/j.pharma.2021.11.004_bib1475","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000195780.37277.2a","article-title":"Increased serum levels of 8-Hydroxy-2\u2032-Deoxyguanosine in clinical depression","volume":"68","author":"Forlenza","year":"2006","journal-title":"Psychosom Med"},{"key":"10.1016\/j.pharma.2021.11.004_bib1480","first-page":"4","article-title":"Oxidative stress and schizophrenia","volume":"2","author":"Dong","year":"2017","journal-title":"J Psychiatry Brain Sci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1485","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","article-title":"Medicine: the kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin","volume":"310","author":"Shaw","year":"2005","journal-title":"Science (80-)"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib1490","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/oxfordjournals.schbul.a007142","article-title":"Increased nitric oxide radicals in postmortem brain from patients with schizophrenia","volume":"30","author":"Yao","year":"2004","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pharma.2021.11.004_bib1495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0009-8981(94)05976-Y","article-title":"Measurement of serum lipid peroxidation during exercise using three different methods: diene conjugation, thiobarbituric acid reactive material and fluorescent chromolipids","volume":"234","author":"Vasankari","year":"1995","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharma.2021.11.004_bib1500","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2005.10.011","article-title":"Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics","volume":"81","author":"Zhang","year":"2006","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib1505","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/j.1471-4159.2004.02575.x","article-title":"Effects of post-injury hypothermia and nerve growth factor infusion on antioxidant enzyme activity in the rat: implications for clinical therapies","volume":"90","author":"DeKosky","year":"2004","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1510","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jnr.20280","article-title":"Peroxide detoxification by brain cells","volume":"79","author":"Dringen","year":"2005","journal-title":"J Neurosci Res"},{"issue":"10","key":"10.1016\/j.pharma.2021.11.004_bib1515","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1046\/j.1460-9568.2000.00229.x","article-title":"Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo","volume":"12","author":"Do","year":"2000","journal-title":"Eur J Neurosci"},{"issue":"6","key":"10.1016\/j.pharma.2021.11.004_bib1520","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3956(98)00028-4","article-title":"Effects of haloperidol on antioxidant defense system enzymes in schizophrenia","volume":"32","author":"Yao","year":"1998","journal-title":"J Psychiatr Res"},{"issue":"2\u20133","key":"10.1016\/j.pharma.2021.11.004_bib1525","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-1781(00)00230-4","article-title":"Abnormal age-related changes of plasma antioxidant proteins in schizophrenia","volume":"97","author":"Yao","year":"2000","journal-title":"Psychiatry Res"},{"issue":"33","key":"10.1016\/j.pharma.2021.11.004_bib1530","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0920-9964(02)00407-3","article-title":"Reduced plasma antioxidants in first-episode patients with schizophrenia","volume":"62","author":"Reddy","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1535","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1016\/S0021-9258(18)61082-8","article-title":"The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells","volume":"262","author":"Heinecke","year":"1987","journal-title":"J Biol Chem"},{"issue":"27","key":"10.1016\/j.pharma.2021.11.004_bib1540","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.pharma.2021.11.004_bib1545","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/archpsyc.64.1.31","article-title":"Elevated prenatal homocysteine levels as a risk factor for schizophrenia","volume":"64","author":"Brown","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"10.1016\/j.pharma.2021.11.004_bib1550","doi-asserted-by":"crossref","first-page":"2361S","DOI":"10.1093\/jn\/132.8.2361S","article-title":"Elevation in S-Adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology","volume":"132","author":"Jill James","year":"2002","journal-title":"J Nutr"},{"issue":"5","key":"10.1016\/j.pharma.2021.11.004_bib1555","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nrn2132","article-title":"Epigenetic regulation in psychiatric disorders","volume":"8","author":"Tsankova","year":"2007","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"10.1016\/j.pharma.2021.11.004_bib1560","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s00018-007-6526-z","article-title":"Epigenetic mechanisms in the context of complex diseases","volume":"64","author":"Van Vliet","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"46","key":"10.1016\/j.pharma.2021.11.004_bib1565","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1523\/JNEUROSCI.3797-08.2008","article-title":"Epigenetics in the nervous system","volume":"28","author":"Jiang","year":"2008","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.pharma.2021.11.004_bib1570","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1021\/jm00263a008","article-title":"Analogs of S-Adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis and biological activity of homocysteine derivatives bridged to adenine","volume":"16","author":"Coward","year":"1972","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.pharma.2021.11.004_bib1575","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0006-2952(72)90114-1","article-title":"Inhibition of catechol-O-methyltransferase by S-adenosylhomocysteine and S-adenosylhomocysteine sulfoxide, a potential transition-state analog","volume":"21","author":"Coward","year":"1972","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1016\/j.pharma.2021.11.004_bib1580","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1021\/bi00736a017","article-title":"Kinetic studies on Catechol O-Methyltransferase. Product inhibition and the nature of the catechol binding site","volume":"12","author":"Coward","year":"1973","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.pharma.2021.11.004_bib1585","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/mp.2009.33","article-title":"Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia","volume":"15","author":"Yao","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharma.2021.11.004_bib1590","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF03033337","article-title":"The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion","volume":"1","author":"Smythies","year":"1999","journal-title":"Neurotox Res"},{"issue":"3","key":"10.1016\/j.pharma.2021.11.004_bib1595","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0920-9964(02)00405-X","article-title":"Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia","volume":"62","author":"Grima","year":"2003","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1600","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1385\/BTER:98:2:109","article-title":"Plasma manganese, selenium, zinc, copper, and iron concentrations in patients with schizophrenia","volume":"98","author":"Yanik","year":"2004","journal-title":"Biol Trace Elem Res"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1605","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s12011-008-8230-8","article-title":"Zinc, manganese, calcium, copper, and cadmium level in scalp hair samples of schizophrenic patients","volume":"127","author":"Rahman","year":"2009","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1610","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","article-title":"Toxicity of iron and hydrogen peroxide: the Fenton reaction","volume":"83","author":"Winterbourn","year":"1995","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-977X(02)00073-1","article-title":"Serum iron levels in schizophrenic patients with or without akathisia","volume":"13","author":"Kuloglu","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib1620","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0891-5849(98)00216-0","article-title":"Mitochondrial damage induced by conditions of oxidative stress","volume":"26","author":"Kowaltowski","year":"1999","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/j.pharma.2021.11.004_bib1625","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(97)00065-1","article-title":"et al., 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes","volume":"80","author":"Keller","year":"1997","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib1630","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archgenpsychiatry.2010.22","article-title":"Mitochondrial complex i activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder","volume":"67","author":"Andreazza","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.pharma.2021.11.004_bib1635","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/appi.ajp.161.2.305","article-title":"Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia","volume":"161","author":"Hazlett","year":"2004","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.pharma.2021.11.004_bib1640","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.pharma.2021.11.004_bib1645","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1017\/S1461145799001649","article-title":"Increased mitochondrial complex I activity in platelets of schizophrenic patients","volume":"2","author":"Ben-Shachar","year":"1999","journal-title":"Int J Neuropsychopharmacol"},{"issue":"7","key":"10.1016\/j.pharma.2021.11.004_bib1650","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.biopsych.2003.12.012","article-title":"Ben. Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study","volume":"55","author":"Karry","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharma.2021.11.004_bib1655","series-title":"Global health estimates","year":"2012"},{"key":"10.1016\/j.pharma.2021.11.004_bib1660","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.5830\/CVJA-2015-038","article-title":"The burden of stroke in Africa: a glance at the present and a glimpse into the future","volume":"26","author":"Mayowa O","year":"2015","journal-title":"Cardiovasc J Afr"},{"key":"10.1016\/j.pharma.2021.11.004_bib1665","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","article-title":"Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis","volume":"17","author":"Deb","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0073481","article-title":"Aquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia\/reperfusion injury in rodents","volume":"8","author":"Bhattacharya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2021.11.004_bib1675","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pathophys.2009.12.001","article-title":"Pathophysiologic mechanisms of acute ischemic stroke: an overview with emphasis on therapeutic significance beyond thrombolysis","volume":"17","author":"Deb","year":"2010","journal-title":"Pathophysiology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1680","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic cell death in brain neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol Rev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1685","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3389\/fphys.2018.00477","article-title":"Role of ROS and nutritional antioxidants in human diseases","volume":"0","author":"Liu","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1690","doi-asserted-by":"crossref","first-page":"e06216","DOI":"10.1016\/j.heliyon.2021.e06216","article-title":"Natural antioxidants for neuroinflammatory disorders and possible involvement of Nrf2 pathway: a review","volume":"7","author":"Singh","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.pharma.2021.11.004_bib1695","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1700","first-page":"1","article-title":"An insight of vitamin E as neuroprotective agents","author":"Yap","year":"2020","journal-title":"Prog Microbes Mol Biol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1705","first-page":"1","article-title":"Role of vitamin E in the treatment of Alzheimer's disease: evidence from animal models","author":"Gugliandolo","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1710","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3233\/JAD-2005-8309","article-title":"Appearance of amyloid beta-like substances and delayed-type apoptosis in rat hippocampus CA1 region through aging and oxidative stress","volume":"8","author":"Fukui","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharma.2021.11.004_bib1715","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.neuropharm.2004.06.029","article-title":"Alpha-tocotrienol provides the most potent neuroprotection among vitamin E analogs on cultured striatal neurons","volume":"47","author":"Osakada","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1720","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/B978-0-12-407824-6.00063-X","article-title":"Vitamin D and the association with cognitive performance, cognitive decline, and dementia","author":"Brouwer-Brolsma","year":"2015","journal-title":"Diet Nutr Dement Cogn Decline"},{"key":"10.1016\/j.pharma.2021.11.004_bib1725","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exger.2015.01.049","article-title":"Vitamin D and white matter abnormalities in older adults: a quantitative volumetric analysis of brain MRI","volume":"63","author":"Annweiler","year":"2015","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1730","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1212\/WNL.0b013e3181beecb7","article-title":"25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services","volume":"74","author":"Buell","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1735","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000000755","article-title":"Vitamin D and the risk of dementia and Alzheimer disease","volume":"83","author":"Littlejohns","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharma.2021.11.004_bib1740","doi-asserted-by":"crossref","first-page":"e0204853","DOI":"10.1371\/journal.pone.0204853","article-title":"Regulation of the NRF2 transcription factor by andrographolide and organic extracts from plant endophytes","volume":"13","author":"Wong","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2021.11.004_bib1745","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.phymed.2018.06.014","article-title":"Andalucin from Artemisia lannta suppresses the neuroinflammation via the promotion of Nrf2-mediated HO-1 levels by blocking the p65-p300 interaction in LPS-activated BV2 microglia","volume":"51","author":"Wang","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharma.2021.11.004_bib1750","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1440-1681.2011.05633.x","article-title":"Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer","volume":"39","author":"Lim","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1755","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10571-019-00656-w","article-title":"Artemisia amygdalina upregulates Nrf2 and protects neurons against oxidative stress in Alzheimer disease","volume":"39","author":"Sajjad","year":"2019","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1760","first-page":"483646","article-title":"Evaluation of artemisia amygdalina D. for anti-inflammatory and immunomodulatory potential","volume":"2013","author":"Mubashir","year":"2013","journal-title":"ISRN Inflamm"},{"key":"10.1016\/j.pharma.2021.11.004_bib1765","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3389\/fphar.2018.00548","article-title":"Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer's disease","volume":"9","author":"Shal","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1770","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11064-014-1326-y","article-title":"Protective effect of naringenin in experimental ischemic stroke: down-regulated NOD2, RIP2, NF-\u03baB, MMP-9 and Up-regulated Claudin-5 expression","volume":"39","author":"Bai","year":"2014","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1775","doi-asserted-by":"crossref","first-page":"9348046","DOI":"10.1155\/2018\/9348046","article-title":"Herbal compounds play a role in neuroprotection through the inhibition of microglial activation","volume":"2018","author":"Fu","year":"2018","journal-title":"J Immunol Res"},{"key":"10.1016\/j.pharma.2021.11.004_bib1780","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/00207454.2018.1545772","article-title":"Neuroprotective effect of naringenin against MPTP-induced oxidative stress","volume":"129","author":"Sugumar","year":"2018","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1785","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/jf035079g","article-title":"Effect of antioxidant Flavanone, Naringenin, from Citrus junos on neuroprotection","volume":"52","author":"Heo","year":"2004","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.pharma.2021.11.004_bib1790","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41398-018-0232-5","article-title":"Antiapoptotic effects of cannabidiol in an experimental model of cognitive decline induced by brain iron overload","volume":"8","author":"da Silva","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.pharma.2021.11.004_bib1795","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1515\/jbcpp-2015-0071","article-title":"Anti-inflammatory effects of the cannabidiol derivative dimethylheptyl-cannabidiol \u2013 studies in BV-2 microglia and encephalitogenic T cells","volume":"27","author":"Juknat","year":"2016","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1800","doi-asserted-by":"crossref","first-page":"e28668","DOI":"10.1371\/journal.pone.0028668","article-title":"Cannabidiol reduces A\u03b2-induced neuroinflammation and promotes hippocampal neurogenesis through PPAR\u03b3 involvement","volume":"6","author":"Esposito","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2021.11.004_bib1805","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejphar.2017.05.004","article-title":"Tenuigenin inhibits LPS-induced inflammatory responses in microglia via activating the Nrf2-mediated HO-1 signaling pathway","volume":"809","author":"Wang","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1810","first-page":"108","article-title":"Exercise and nutraceuticals: eminent approach for diabetic neuropathy","author":"Kale","year":"2021","journal-title":"Curr Mol Pharmacol"},{"key":"10.1016\/j.pharma.2021.11.004_bib1815","doi-asserted-by":"crossref","first-page":"801418","DOI":"10.1155\/2013\/801418","article-title":"Curcumin pretreatment induces Nrf2 and an antioxidant response and prevents hemin-induced toxicity in primary cultures of cerebellar granule neurons of rats","volume":"2013","author":"Gonz\u00e1lez-Reyes","year":"2013","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.pharma.2021.11.004_bib1820","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neulet.2015.03.045","article-title":"Curcumin inhibits A\u03b2-induced microglial inflammatory responses in vitro: involvement of ERK1\/2 and p38 signaling pathways","volume":"594","author":"Shi","year":"2015","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharma.2021.11.004_bib1825","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13578-017-0146-6","article-title":"Upregulation of heme oxygenase-1 expression by curcumin conferring protection from hydrogen peroxide-induced apoptosis in H9c2 cardiomyoblasts","volume":"7","author":"Yang","year":"2017","journal-title":"Cell Biosci"},{"key":"10.1016\/j.pharma.2021.11.004_bib1830","doi-asserted-by":"crossref","first-page":"e61052","DOI":"10.1371\/journal.pone.0061052","article-title":"Suppression of neuroinflammatory and apoptotic signaling cascade by curcumin alone and in combination with piperine in rat model of olfactory bulbectomy induced depression","volume":"8","author":"Rinwa","year":"2013","journal-title":"PLoS One"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921001759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450921001759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T23:37:05Z","timestamp":1757720225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450921001759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":183,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0003450921001759"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2021.11.004","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interweaving of reactive oxygen species and major neurological and psychiatric disorders","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}